Scribd
Upload
6 views2 pages

Atrial Fibrillation Anticoagulation Audit

This document is an audit questionnaire for assessing anticoagulation management in patients with Atrial Fibrillation at Aziz Bhatti Shaheed Teaching Hospital. It includes sections on patient identification, clinical background, risk stratification, anticoagulation management, and clinical governance. The questionnaire aims to evaluate the appropriateness of anticoagulation therapy and related clinical practices.

Uploaded by

doctormujahid09
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
6 views2 pages

Atrial Fibrillation Anticoagulation Audit

This document is an audit questionnaire for assessing anticoagulation management in patients with Atrial Fibrillation at Aziz Bhatti Shaheed Teaching Hospital. It includes sections on patient identification, clinical background, risk stratification, anticoagulation management, and clinical governance. The questionnaire aims to evaluate the appropriateness of anticoagulation therapy and related clinical practices.

Uploaded by

doctormujahid09
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd

Audit Questionnaire

Title: Audit of Anticoagulation in Patients with Atrial Fibrillation (AF)


Department of Cardiology, Aziz Bhatti Shaheed Teaching Hospital

Patient Identification
Patient ID (initials/code)
Age
Sex
OPD Visit Date
Consultant/Registrar

Section 1: Diagnosis and Clinical Background


1. Type of Atrial Fibrillation:
☐ Paroxysmal ☐ Persistent ☐ Permanent ☐ Not documented

2. Duration since diagnosis of AF:


☐ <6 months ☐ 6–12 months ☐ >1 year ☐ Not known

3. Cause/Etiology of AF (if known):


☐ Hypertension ☐ Valvular Disease ☐ Ischemic Heart Disease
☐ Thyrotoxicosis ☐ Post-operative ☐ Idiopathic ☐ Other: __________

4. Relevant co-morbidities (tick all applicable):


☐ Hypertension ☐ Diabetes Mellitus ☐ Stroke/TIA ☐ Congestive Heart Failure ☐ Coronary
Artery Disease
☐ CKD (Stage ___) ☐ Liver Disease ☐ Malignancy ☐ Bleeding history ☐ Dementia ☐
Falls/Frailty ☐ None

Section 2: Risk Stratification


5. Is the CHA₂DS₂-VASc score documented?
☐ Yes → Score: ____ ☐ No

6. Your calculated CHA₂DS₂-VASc score (if not documented): [___]

7. Is the HAS-BLED score documented?


☐ Yes → Score: ____ ☐ No

8. Your calculated HAS-BLED score (if not documented): [___]

9. Is anticoagulation indicated based on CHA₂DS₂-VASc?


☐ Yes ☐ No ☐ Borderline

10. Is bleeding risk high (HAS-BLED ≥3)?


☐ Yes ☐ No
Section 3: Anticoagulation Management
11. Is the patient on anticoagulation?
☐ Yes ☐ No → Reason: ☐ Refusal ☐ Contraindication ☐ Not assessed ☐ Other

12. If anticoagulated, which agent?


☐ Warfarin ☐ Apixaban ☐ Rivaroxaban ☐ Dabigatran ☐ Edoxaban ☐ Other

13. If on warfarin:
- INR frequency: ☐ Weekly ☐ Fortnightly ☐ Monthly ☐ Unknown
- Latest INR: ____
- In therapeutic range? ☐ Yes ☐ No

14. Counselling done?


☐ Yes – documented ☐ Yes – verbal ☐ No ☐ Unclear

15. Shared decision-making documented?


☐ Yes ☐ No ☐ Unclear

16. Bleeding risk mitigated (tick all):


☐ BP control ☐ Renal/liver monitoring ☐ NSAIDs avoided ☐ Fall risk assessed ☐ PPI given
☐ None

Section 4: Clinical Governance/Follow-up


17. Follow-up scheduled?
☐ Yes ☐ No

18. Re-evaluation planned?


☐ Yes → After ___ months ☐ No plan ☐ Not applicable

19. Referrals made?


☐ Yes → Specify: __________ ☐ No ☐ Not applicable

20. Audit Assessor’s Impression:


☐ Well-managed ☐ Needs improvement ☐ Unsafe

Additional Notes/Comments
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________

Sign-Off
Data Collected by: ___________________
Designation: ___________________
Date: ___________________

You might also like